UK coronavirus variant shouldn't impact remdesivir effectiveness, Gilead CEO says 01/12/2021 Health News, Study out of Wuhan, China, claims coronavirus symptoms can last at least 6 months Dr....
Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint 09/06/2018 Medications, FOSTER CITY, Calif. & MECHELEN, Belgium--(BUSINESS WIRE)--Sep. 6, 2018-- Gilead Sciences, Inc. (NASDAQ:GILD) and Galapagos...